These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 24038740

  • 1. Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.
    Siudak Z, Dziewierz A, Rakowski T, Żmudka K, Legutko J, Bartuś S, Dragan J, Zasada W, Tokarek T, Kułaga T, Partyka Ł, Dudek D.
    Catheter Cardiovasc Interv; 2014 Feb 15; 83(3):436-42. PubMed ID: 24038740
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.
    JACC Cardiovasc Interv; 2013 Jun 15; 6(6):548-53. PubMed ID: 23683734
    [Abstract] [Full Text] [Related]

  • 3. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M, Tebaldi M, Borghesi M, Vranckx P, Campo G, Tumscitz C, Cangiano E, Minarelli M, Scalone A, Cavazza C, Marchesini J, Parrinello G, PRODIGY Investigators.
    JACC Cardiovasc Interv; 2014 Jan 15; 7(1):20-8. PubMed ID: 24332420
    [Abstract] [Full Text] [Related]

  • 4. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, Fusaro M, Schneider S, Schulz S, Ibrahim T, Ott I, Massberg S, Laugwitz KL, Kastrati A.
    JACC Cardiovasc Interv; 2013 Dec 15; 6(12):1267-74. PubMed ID: 24355117
    [Abstract] [Full Text] [Related]

  • 5. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
    Sabaté M, Brugaletta S, Cequier A, Iñiguez A, Serra A, Hernádez-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Backx B, Serruys PW.
    JACC Cardiovasc Interv; 2014 Jan 15; 7(1):64-71. PubMed ID: 24332423
    [Abstract] [Full Text] [Related]

  • 6. Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.
    Jones DA, Rathod KS, Gallagher S, Weerackody R, Knight CJ, Rothman MT, Mathur A, Jain AK, Timmis AD, Wragg A.
    Catheter Cardiovasc Interv; 2013 May 15; 81(6):E237-44. PubMed ID: 22707383
    [Abstract] [Full Text] [Related]

  • 7. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.
    Sarno G, Lagerqvist B, Nilsson J, Frobert O, Hambraeus K, Varenhorst C, Jensen UJ, Tödt T, Götberg M, James SK.
    J Am Coll Cardiol; 2014 Jul 08; 64(1):16-24. PubMed ID: 24998123
    [Abstract] [Full Text] [Related]

  • 8. New generation drug-eluting stents for ST-elevation myocardial infarction: a new paradigm for safety.
    Garg A, Brodie BR, Stuckey TD, Garberich RF, Tobbia P, Hansen C, Kissling G, Kadakia H, Lips D, Henry TD.
    Catheter Cardiovasc Interv; 2014 Nov 15; 84(6):955-62. PubMed ID: 24174334
    [Abstract] [Full Text] [Related]

  • 9. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P.
    J Invasive Cardiol; 2011 Aug 15; 23(8):336-41. PubMed ID: 21828397
    [Abstract] [Full Text] [Related]

  • 10. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R, Kirtane AJ, Torguson R, Cohen DJ, Ryan T, Räber L, Applegate R, Waxman S, Gordon P, Kaneshige K, Leon MB, DESERT Investigators.
    JACC Cardiovasc Interv; 2014 Oct 15; 7(10):1093-102. PubMed ID: 25240540
    [Abstract] [Full Text] [Related]

  • 11. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF, EVENT Investigators.
    Catheter Cardiovasc Interv; 2012 Dec 01; 80(7):1127-36. PubMed ID: 22431166
    [Abstract] [Full Text] [Related]

  • 12. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E, Mangiacapra F, Peace A, Ntarladimas Y, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E.
    Arch Cardiovasc Dis; 2013 Nov 01; 106(11):554-61. PubMed ID: 24231052
    [Abstract] [Full Text] [Related]

  • 13. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
    Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L, DAPT Study Investigators.
    JACC Cardiovasc Interv; 2015 Oct 01; 8(12):1552-62. PubMed ID: 26493248
    [Abstract] [Full Text] [Related]

  • 14. Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
    Buszman PP, Orlik B, Trela B, Milewski K, Kozlowski M, Pruski M, Drzewiecki J, Peppas A, Granada JF, Kaluza GL, Buszman PE.
    Catheter Cardiovasc Interv; 2013 Sep 01; 82(3):E155-62. PubMed ID: 23109067
    [Abstract] [Full Text] [Related]

  • 15. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH, Fang Q, Zhang SY, Shen ZJ, Fan ZJ, Jin XF, Zeng Y, Liu ZY, Xie HZ, Yang M.
    Chin Med J (Engl); 2012 Aug 01; 125(16):2803-6. PubMed ID: 22932070
    [Abstract] [Full Text] [Related]

  • 16. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry.
    Jensen JK, Jensen LO, Terkelsen CJ, Lassen JF, Tilsted HH, Hansen KN, Maeng M, Thuesen L, Thayssen P.
    Catheter Cardiovasc Interv; 2013 Feb 01; 81(2):260-5. PubMed ID: 22511512
    [Abstract] [Full Text] [Related]

  • 17. Long-term clinical outcome in STEMI patients treated with primary PCI and drug-eluting or bare-metal stents: insights from a high-volume single-center registry.
    Pedersen S, Galatius S, Mogelvang R, Abildstrom SZ, Sorensen R, Galloe A, Abildgaard U, Hansen P, Davidsen U, Iversen A, Bech J, Madsen JK, Jensen JS.
    J Invasive Cardiol; 2011 Aug 01; 23(8):328-33. PubMed ID: 21828395
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
    Richardt G, Leschke M, Abdel-Wahab M, Toelg R, El-Mawardy M, Serruys PW, Silber S, Windecker S, Belardi JA, Neumann FJ, Widimsky P, RESOLUTE All Comers, RESOLUTE International Investigators.
    JACC Cardiovasc Interv; 2013 Sep 01; 6(9):905-13. PubMed ID: 23954063
    [Abstract] [Full Text] [Related]

  • 19. No long-term clinical benefit from manual aspiration thrombectomy in ST-elevation myocardial infarction patients. Data from NRDES registry.
    Siudak Z, Mielecki W, Dziewierz A, Rakowski T, Legutko J, Bartuś S, Bryniarski KL, Partyka Ł, Dudek D.
    Catheter Cardiovasc Interv; 2015 Jan 01; 85(1):E16-22. PubMed ID: 24909662
    [Abstract] [Full Text] [Related]

  • 20. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D, Sato A, Hoshi T, Maruta S, Misaki M, Kakefuda Y, Watabe H, Hiraya D, Sakai S, Kawabe M, Takeyasu N, Aonuma K.
    J Cardiol; 2014 Nov 01; 64(5):377-83. PubMed ID: 24685689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.